Please login to the form below

Not currently logged in
Email:
Password:

patient advocacy

This page shows the latest patient advocacy news and features for those working in and with pharma, biotech and healthcare.

Taming the Monster

Taming the Monster

Individual departments are set up to focus on specific stakeholder groups; for example, market access teams focus on payers, PR/communications teams interact with patient advocacy groups and commercial teams engage

Latest news

  • New alliance launches to usher digital therapeutics into the mainstream New alliance launches to usher digital therapeutics into the mainstream

    As the entire industry prepares for what's next, we are excited to represent digital therapeutics in this rapidly evolving environment, working with regulators, patient advocacy groups, providers, payers, and manufacturers.".

  • Pharma’s digital patient engagement innovators identified Pharma’s digital patient engagement innovators identified

    Pharma’ s digital patient engagement innovators identified. Novartis, Pfizer and Sanofi named best-in-class by Decision Resources Group. ... With resources that range from educational videos to healthcare service locators and beyond, the Swiss pharma

  • Facing the new wave of biosimilars Facing the new wave of biosimilars

    Facing the new wave of biosimilars. Don’t drown out the patient voice, says advocacy group. ... Over the past year alone, GAfPA has hosted patient advocacy workshops in Barcelona, Copenhagen, Budapest and at the EU Parliament.

  • Power to the people Power to the people

    This is perhaps unfair. Industry now partners much more effectively with patient advocacy groups, government bodies and other health experts who provide independent input into pharma’s commercial strategies - and companies ... a highly regulated

  • The Communiqué Awards at 20: Mark Flannagan The Communiqué Awards at 20: Mark Flannagan

    What influence have these wins had on your career? The award allowed Beating Bowel Cancer and myself to be seen as a key partner in healthcare and patient advocacy. ... Sir Richard Doll - taught me the benefits of long term, evidence based advocacy.

More from news
Approximately 3 fully matching, plus 96 partially matching documents found.

Latest Intelligence

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    Patient outcomes in practice: delivering value that transforms lives. Over the next five years, the NHS needs to drive efficiencies of £22bn. ... incorporating patient-reported outcomes measures in real-world data programmes, and patient advocacy support

  • GDPR and the NHS ‘opt out’: a chance to engage patients in research GDPR and the NHS ‘opt out’: a chance to engage patients in research

    Consequently, patient advocacy groups, such as UseMYData, are now championing the appropriate use of patient data for research. ... In other words, informed consent underpins not only patient centricity but the future of research.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    appropriate. Patients themselves can also be empowered to become ‘experts in their disease’and utilise information developed by the patient advocacy groups, often in collaboration with biopharmaceutical companies. ... On top of communicating

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    appropriate. Patients themselves can also be empowered to become ‘experts in their disease’and utilise information developed by the patient advocacy groups, often in collaboration with biopharmaceutical companies. ... On top of communicating

  • Six degrees of participation Six degrees of participation

    Evidence suggests there’s a real appetite for pharma to get involved - especially among patient advocacy groups who recognise the skills and knowledge the industry can offer, ”says Richard Jones, managing ... For example, our recent work to design a

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Leider’s new role as chief medical officer will see him take responsibility for leading Gelesis’overall medical strategy, including overseeing medical affairs functions and programming with medical associations, patient advocacy

  • Pegasus bolsters team Pegasus bolsters team

    Former HAVAS Just employee, Harriet Middleton joins the company as its senior account director following a background in healthcare public affairs and experience in stakeholder relations, policy and patient advocacy.

  • Clark Health Communications expands team Clark Health Communications expands team

    Formerly serving at Ketchum in London and Cube Public Relations in Sydney, Moore’s expertise lies in healthcare communications, PR and patient advocacy.

  • AZ’s Kelly Teasdale moves to Burson-Marsteller AZ’s Kelly Teasdale moves to Burson-Marsteller

    Most recently, Teasdale served as global brand communications director at AstraZeneca, where she was responsible for the firm's global patient advocacy and patient-centricity communication strategies for oncology and cardiovascular ... develop our

  • Daniel Beach moves from Ketchum to Portland Health Daniel Beach moves from Ketchum to Portland Health

    Daniel complements the existing senior team expertise with extensive global communications experience and invaluable insights from his in-house and patient advocacy roles. “

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics